France· FR:65220909
XEROQUEL LP 400 mg, comprimé à libération prolongée
A medicinal product containing quétiapine (fumarate de), registered in France by DIFARMED (ESPAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- QUÉTIAPINE (FUMARATE DE)
- Manufacturer
- DIFARMED (ESPAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400949002054plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC-Aluminium de 30 comprimé(s)EUR 51.71
- cip133400949002061plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC-Aluminium de 60 comprimé(s)EUR 103.01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Quétiapine (fumarate de) in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDERIN PROLONGVipharm S.A., Ożarów Mazowiecki
- SpainATROLAK PROLONG 400MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGAccord Healthcare S.L.U.
- United KingdomAtrolak XL 400mg tabletsAccord-UK Ltd
- United StatesQuetiapineREMEDYREPACK INC.
- FinlandBiquetanSTADA Arzneimittel AG
- BelgiumQuetiapin Retard Sandoz 400 mgSandoz
- CanadaACH-QUETIAPINE FUMARATE XRACCORD HEALTHCARE INC
- NorwayKwetaplex XRAdamed Pharma
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Quetialan, Quetialan 4 Tage Startpackung
- Belgium · Ketyalix, Quetiapin Retard Sandoz
- Bulgaria · Centroqueen, Бревенокс
- Cyprus · Aquetia, Ketipine
- Czechia · Derin, Derin Prolong
- Germany · Aquetia, Desiquet
- Denmark · Antoreq, Biquetan
- Estonia · Ketipinor, Kventiax
- Spain · Atrolak Prolong, Ketyalix
- Finland · Biquetan, Ketipinor
- United Kingdom (Northern Ireland) · Alaquet Xl, Atrolak Xl
- Greece · Anaquetan Xr, Aquetia
- Croatia · Kventiax, Kventiax Sr
- Hungary · Ketilept, Ketilept Prolong
- Ireland · Notiabolfen Xl, Quentiax Sr
- Iceland · Quetiapin Actavis, Quetiapin Krka
- Italy · Akelya, Quentiax
- Lithuania · Hedonin, Ketipinor
- Luxembourg · Aquetia, Quetiapine Eg
- Latvia · Ketipinor, Kventiax
- Malta · Quetex, Quetex Xr 50mg
- Netherlands · Aquetia, Quetiapine
- Norway · Quetiapin Krka, Quetiapin Orion
- Poland · Apotiapina, Apotiapina Pr
- Portugal · Anaquetan Xr, Aquetia
- Romania · Kventiax, Kventiax Ep
- Sweden · Biquetan, Quetiapin Hexal
- Slovenia · Kvelux, Kvelux Sr
- Slovakia · Derin, Derin Prolong
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1856d9e-4e82-4fc8-8094-ec7cecd4220d GET /v1/drugs/c1856d9e-4e82-4fc8-8094-ec7cecd4220d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65220909",
"date_amm": "2017-05-30",
"type_amm": "Autorisation d'importation parallèle",
"numero_ue": null,
"substance": "QUÉTIAPINE (FUMARATE DE)",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about quétiapine (fumarate de).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.